THIS WEBSITE IS FOR HEALTHCARE PROFESSIONALS ONLY

This website contains promotional information on Defitelio▼ (defibrotide) and has been developed in-line with EU marketing authorisation. Please consult local prescribing information for further information.

By entering this site, you are confirming that you are a healthcare professional within your selected country.

Please select the country of your practice to continue:

By clicking continue, you will be leaving the Defitelio EU website and directed to the #### website where the information is intended only for healthcare professionals within this country.

By continuing, you hereby confirm that you are a healthcare professional and that you reside and practice within the country that you have selected.

Adverse events should be reported. Healthcare professionals are asked to report any suspected adverse events via their national reporting system. Adverse events should also be reported to Jazz Pharmaceuticals by email to aereporting@jazzpharma.com.

▼ - This medicinal product is subject to additional monitoring

This website is funded by Jazz Pharmaceuticals, and contains promotional content. This content is intended for Healthcare Professionals only.

WELCOME TO THE DEFITELIO^®(Defibrotide) PORTAL

THIS WEBSITE IS FOR HEALTHCARE PROFESSIONALS ONLY

This website is funded by Jazz Pharmaceuticals, and contains promotional content. This content is intended for Healthcare Professionals only.

WELCOME TO THE DEFITELIO® (Defibrotide) PORTAL

THIS WEBSITE IS FOR HEALTHCARE PROFESSIONALS ONLY

Terms of Use

JAZZ PHARMACEUTICALS — PRIVACY STATEMENT

Prescribing Information

You are being directed to the Jazz Corporate Website

You are being directed to the Jazz Corporate Website

You are being directed to the Knowledge Network Members Area

Adverse events should be reported.

Learning Centre Forgotten Password

Learning Centre Registration

Important Information

Important Information

WELCOME TO THE DEFITELIO^®(Defibrotide) PORTAL